CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY

该项目将建立一个集中的制剂来源， 化学预防计划的临床前和临床研究 国家癌症研究所（NCI）。对于临床前研究， 将提供：购买散装试剂化学物质; 供应商代理;安全稳定的储存;重新包装代理，以满足 用户需求;以及向用户运送制剂， 表征数据和处理说明。对于供应商;安全和 稳定储存;给药制剂所需的管理支持， 封装、日历包装和标签，包括运往NCI 如有需要，指定承办商完成这些工作;以及 运送到最终目的地。为全面实现千年发展目标开展的基本活动 业务包括：监测用户地点的库存水平;库存 控制，以确保及时重新订购，并运送代理商;维护 最新的货运记录;有限的质量保证 散装制剂的保质期和纯度等能力。

This project would establish a centralized source of agents for use in preclinical and clinical studies by the chemoprevention program of the National Cancer Institute (NCI). For preclinical studies, the project would provide: purchase of bulk reagent chemical substances; receipt of agents from suppliers; safe and stable storage; repacking agents to meet user needs; and shipment of agents to users with appropriate characterization data and handling instructions. For suppliers; safe and stable storage; administrative support as needed for dosage formulation, encapsulation, calendar packing and labeling, including shipment to NCI designated contractors to accomplish these tasks if necessary; and shipment to final destination. Essential activities for the overall operation include: monitoring stock levels at user locations; inventory control to ensure timely reordering, and shipping of agents; maintenance of up-to-date records of shipments; and limited quality assurance capability such as shelf life and purity of bulk agents.